Literature DB >> 11334936

Transporters in African trypanosomes: role in drug action and resistance.

H P de Koning1.   

Abstract

Sleeping sickness is an increasing problem in many parts of sub-Saharan Africa. The problems are compounded by the lack of new medication, and the increasing resistance against traditional drugs such as melarsoprol, berenil and isometamidium. Over the last few years, much progress has been made in understanding how drug action, and the development of resistance, is related to the mechanisms by which the parasite ingests the drugs. In some cases novel transporters have been identified. In other cases, transporters do not appear to be involved in drug uptake, and selectivity must lie with other parasite features, such as a specific target or activation of the drug. Lessons learned from studying the uptake of drugs currently in use may assist the design of a much needed new generation of trypanocides.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11334936     DOI: 10.1016/s0020-7519(01)00167-9

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  25 in total

1.  Accumulation and intracellular distribution of antitrypanosomal diamidine compounds DB75 and DB820 in African trypanosomes.

Authors:  Amanda M Mathis; Jacqueline L Holman; Lisa M Sturk; Mohamed A Ismail; David W Boykin; Richard R Tidwell; James Edwin Hall
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

2.  Parallel synthesis of a series of non-functional ATP/NAD analogs with activity against trypanosomatid parasites.

Authors:  Andreas Link; Philipp Heidler; Marcel Kaiser; Reto Brun
Journal:  Mol Divers       Date:  2009-05-30       Impact factor: 2.943

3.  Purine nucleobase transport in amastigotes of Leishmania mexicana: involvement in allopurinol uptake.

Authors:  Mohammed I Al-Salabi; Harry P de Koning
Journal:  Antimicrob Agents Chemother       Date:  2005-09       Impact factor: 5.191

4.  Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei.

Authors:  Enock Matovu; Mhairi L Stewart; Federico Geiser; Reto Brun; Pascal Mäser; Lynsey J M Wallace; Richard J Burchmore; John C K Enyaru; Michael P Barrett; Ronald Kaminsky; Thomas Seebeck; Harry P de Koning
Journal:  Eukaryot Cell       Date:  2003-10

5.  The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in african trypanosomes.

Authors:  Harry P de Koning; Laura F Anderson; Mhairi Stewart; Richard J S Burchmore; Lynsey J M Wallace; Michael P Barrett
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 6.  Aquaglyceroporins and metalloid transport: implications in human diseases.

Authors:  Hiranmoy Bhattacharjee; Barry P Rosen; Rita Mukhopadhyay
Journal:  Handb Exp Pharmacol       Date:  2009

Review 7.  Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis.

Authors:  Andrew Jonathan Nok
Journal:  Parasitol Res       Date:  2003-01-31       Impact factor: 2.289

8.  Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein.

Authors:  Lisa Sanderson; Murat Dogruel; Jean Rodgers; Harry Pieter De Koning; Sarah Ann Thomas
Journal:  J Pharmacol Exp Ther       Date:  2009-03-04       Impact factor: 4.030

Review 9.  Human African trypanosomiasis: pharmacological re-engagement with a neglected disease.

Authors:  M P Barrett; D W Boykin; R Brun; R R Tidwell
Journal:  Br J Pharmacol       Date:  2007-07-09       Impact factor: 8.739

10.  Diphenyl furans and aza analogs: effects of structural modification on in vitro activity, DNA binding, and accumulation and distribution in trypanosomes.

Authors:  Amanda M Mathis; Arlene S Bridges; Mohamed A Ismail; Arvind Kumar; Iris Francesconi; Mariappan Anbazhagan; Qiyue Hu; Farial A Tanious; Tanja Wenzler; Janelle Saulter; W David Wilson; Reto Brun; David W Boykin; Richard R Tidwell; James Edwin Hall
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.